Sci Rep. 2018 Jan 18;8(1):1456. doi: 10.1038/s41598-018-19645-y.

Publisher Correction: EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma.

Fan CC^1,², Cheng WC^3,⁴, Huang YC^5,⁶, Sher YP^4,⁷, Liou NJ⁷, Chien YC⁴, Lin PS⁷, Lin PS⁷, Chen CH^8,^9,^10,¹¹, Chang WC¹².

1: Department of Superintendent Office, Mackay Memorial Hospital, Taipei, Taiwan.
2: Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsinchu, Taiwan.
3: Research Center for Tumor Medical Science, China Medical University, Taichung, Taiwan.
4: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
5: School of Chinese Medicine, China Medical University, Taichung, Taiwan.
6: Genetics Center, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
7: Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan.
8: Genomics Research Center, Academia Sinica, Taipei, Taiwan.
9: Institute of Biochemistry & Molecular Biology, National Yang-Ming University, Taipei, Taiwan.
10: Department of Chemistry, National Taiwan University, Taipei, Taiwan.
11: Institute of Atomic & Molecular Sciences, Academia Sinica, Taipei, Taiwan.
12: Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan. T21443@mail.cmuh.org.tw.